1-(3-BROMOPHENYL)-2,2,2-TRIFLUOROETHANAMINE, 95.0%, 5g

Methyl 3,5-Diamino-6-chloropyrazine-2-carboxylate>98.0%(GC)(T)25g

FR180204, 95.0%, 50mg

Trial kit Spectra/Por® 1-3 Spectra/Por® 1 – MWCO 6000–8000, 32 mm, 1 Piece(s)

4-(Methoxycarbonyl)-3-nitrobenzoic acid, 95.0%, 1g

1-(2,4-dimethylphenyl)ethanamine, 95.0%, 5g

(R)-2-Amino-3-(2,4,5-trifluorophenyl)propanoic acid, 95.0%, 5g

4,6-DIBROMO-3-HYDROXY-2-NITROBENZOIC ACID, 95%, 100mg

(R)-2-(3-(Diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenol (R)-2-acetoxy-2-phenylacetate, 98%, 250mg

Citric acid monohydrate, min. 99.5%, Ph.Eur., 2.5 kg, plastic packaging.

tert-butyl 3-(bromomethyl)-3-hydroxyazetidine-1-carboxylate, 95.0%, 100mg

3-Chloro-6-cyclopropylpyridazine, 95.0%, 100mg

[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-2-AMINE, 95.0%, 1g